학술논문
Frequency of HER2 expression of circulating tumour cells in patients with metastatic or recurrent gastrointestinal cancer.
Document Type
Article
Author
Source
Subject
*CANCER cells
*TUMORS
*GASTROINTESTINAL cancer
*METASTASIS
*HER2 gene
*
*
*
*
Language
ISSN
0007-0920
Abstract
Background:The clinical significance of circulating tumour cell (CTC) detection in gastrointestinal (GI) cancer remains controversial and the molecular biological characteristics of CTCs are poorly understood.Methods:A total of 87 patients with metastatic or recurrent GI cancer were prospectively enrolled. Circulating tumour cells and their HER2 status were assessed using the CellSearch System.Results:Among the 62 CTC-positive cases, we found 22 discordant cases (35.5%). Among the HER2-negative primary tumours, 17 of 54 developed HER2-positive CTCs. Five of eight had HER2-negative CTCs among the HER2-positive primary tumours.Conclusion:The findings in the current study suggest that it is critical to evaluate the HER2 status of not only the primary tumour but also the CTCs because the metastasising tumour cells are the primary target of systemic therapy. [ABSTRACT FROM AUTHOR]